FDA NDC Directory · JSON-LD · Markdown
NDC 58160-725 · VACCINE · SUSPENSION
| Generic name | influenza virus vaccine |
|---|---|
| Labeler / Manufacturer | GlaxoSmithKline Biologicals SA |
| Marketing category | Biologic License Application · App BLA125127 |
| Dosage form / route | SUSPENSION · INTRAMUSCULAR |
| Active ingredients | INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL) INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL) INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL) |
| Marketing started | 20260701 |
| Marketing ended | 20270630 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).